Freeline climbs on $28 mln buyout deal by Syncona
22/11/2023 14:14
** U.S.-listed shares of UK-based therapy developer Freeline
Therapeutics FRLN.O rise ~9.2% to $6.31 premarket
** Guernsey-based healthcare company Syncona SYNCS.L is
acquiring Freeline in all-cash deal valued at $28.3 million -
FRLN
** FRLN says it will receive $6.50 per share held,
representing a premium of 12.5% to the stock's last close
** Deal is expected to close in the first quarter of 2024
** Up to last close, stock down 18.9% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))